General Information of the Compound
| Compound ID |
CP0077627
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(-)-swainsonine
Show/Hide
|
||||||||||||||||||
| Synonyms |
Carbohydrate processing inhibitors, GLYCODesign
GD-0039
GD-0039 analogs, GlycoDESIGN
Swainsonine
Swainsonine hydrochloride
Transforming growth factor beta inhibitors, GLYCODesign
Tridolgosir
Tridolgosir hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C8H15NO3
|
||||||||||||||||||
| Molecular Weight |
173.212
|
||||||||||||||||||
| Canonical SMILES |
O[C@@H]1CN2CCC[C@@H](O)[C@@H]2[C@@H]1O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C8H15NO3/c10-5-2-1-3-9-4-6(11)8(12)7(5)9/h5-8,10-12H,1-4H2/t5-,6-,7-,8-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
FXUAIOOAOAVCGD-WCTZXXKLSA-N
|
||||||||||||||||||
| CAS |
72741-87-8
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound